提高风湿病患者的治疗依从性。
Improving treatment adherence in patients with rheumatologic disease.
作者信息
de Achaval Sofia, Suarez-Almazor Maria E
机构信息
Ms Achaval is senior coordinator of clinical trials, and Dr Suarez-Almazor is professor in the department of general internal medicine, ambulatory treatment, and emergency care at the University of Texas M. D. Anderson Cancer Center in Houston. Dr Suarez-Almazor has a K24 career award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and is director and principal investigator of the Houston CERT, one of the Centers for Education & Research on Therapeutics, a multicenter research program funded by the Agency for Healthcare Research and Quality. She has received honoraria as a speaker from Bristol-Myers Squibb, Roche, and Amgen.
出版信息
J Musculoskelet Med. 2010 Oct 12;27(10).
Abstract
Further evaluation of reasons for treatment nonadherence in patients with rheumatologic disease is key in the development of successful interventions. Patient education efforts alone are not sufficient to improve adherence; complex interventions are most effective. Because most rheumatologic diseases require lifetime therapy, the consequences of nonadherence can be deleterious. Several direct and indirect methods have been proposed to measure adherence. Pharmacy claims data have been used frequently in studying rheumatologic disease; electronic monitoring provides an accurate measure. Adherence is mediated through constructs of the patient-physician relationship.
摘要
进一步评估风湿性疾病患者治疗不依从的原因是成功干预措施发展的关键。仅靠患者教育努力不足以提高依从性；复杂的干预措施最有效。由于大多数风湿性疾病需要终身治疗，不依从的后果可能是有害的。已经提出了几种直接和间接的方法来衡量依从性。药房报销数据在研究风湿性疾病中经常被使用；电子监测提供了一种准确的测量方法。依从性是通过医患关系的构建来调节的。
相似文献
1
Improving treatment adherence in patients with rheumatologic disease.提高风湿病患者的治疗依从性。
J Musculoskelet Med. 2010 Oct 12;27(10).
2
Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.缩小差距：确定特定人群不依从的比率和原因。
J Manag Care Spec Pharm. 2019 Nov;25(11):1282-1288. doi: 10.18553/jmcp.2019.25.11.1282.
3
Studying the Digital Intervention Engagement-Mediated Relationship Between Intrapersonal Measures and Pre-Exposure Prophylaxis Adherence in Sexual and Gender Minority Youth: Secondary Analysis of a Randomized Controlled Trial.研究性少数和性别少数青年中人际测量与暴露前预防依从性之间的数字干预参与介导关系：一项随机对照试验的二次分析
J Med Internet Res. 2025 Jan 13;27:e57619. doi: 10.2196/57619.
4
Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.在一个由商业保险和医疗保险成员组成的混合模式管理式医疗组织中，对针对医生和患者的邮件干预措施进行描述性分析，以提高抗高血压和抗糖尿病药物的依从性。
J Manag Care Pharm. 2011 Jun;17(5):355-66. doi: 10.18553/jmcp.2011.17.5.355.
5
Interventions to Improve Medication Adherence: A Review.干预措施以提高用药依从性：综述。
JAMA. 2018 Dec 18;320(23):2461-2473. doi: 10.1001/jama.2018.19271.
6
Contemporary Patterns of Financial Toxicity Among Patients With Rheumatologic Disease in the United States.美国风湿性疾病患者的当代财务毒性模式。
J Clin Rheumatol. 2024 Sep 1;30(6):223-228. doi: 10.1097/RHU.0000000000002110. Epub 2024 Jul 8.
7
Medication adherence: a challenge for patients with postmenopausal osteoporosis and other chronic illnesses.药物依从性：绝经后骨质疏松症患者及其他慢性病患者面临的一项挑战。
J Manag Care Pharm. 2006 Jul;12(6 Suppl A):S20-5; quiz S26-8. doi: 10.18553/jmcp.2006.12.S6-A.S20.
8
Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension.对糖尿病或高血压患者药物依从性的诊断和药房索赔数据编码进行校准。
J Manag Care Spec Pharm. 2021 Apr;27(4):497-506. doi: 10.18553/jmcp.2021.27.4.497.
9
Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.从美国老年人的药房理赔数据中得出的药物（再）填充依从性措施：文献综述。
Drugs Aging. 2013 Jun;30(6):383-99. doi: 10.1007/s40266-013-0074-z.
10
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review.精神分裂症患者的药物依从性：影响依从性的因素及不依从的后果，系统文献回顾。
Ther Adv Psychopharmacol. 2013 Aug;3(4):200-18. doi: 10.1177/2045125312474019.
引用本文的文献
1
What are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines.一线治疗和专科护理中痛风管理的核心建议有哪些？临床实践指南的系统评价。
BMC Rheumatol. 2023 Jun 15;7(1):15. doi: 10.1186/s41927-023-00335-w.
2
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort.系统性硬化症治疗的患者偏好：一项意大利队列中的描述性研究。
J Scleroderma Relat Disord. 2021 Jun;6(2):165-169. doi: 10.1177/2397198320971984. Epub 2020 Dec 3.
3
Support Methodologies for African American Women With Lupus - Comparing Three Methods' Effects on Patient Activation and Coping.针对患有狼疮的非裔美国女性的支持方法——比较三种方法对患者激活和应对的影响。
Front Psychol. 2021 Oct 5;12:734390. doi: 10.3389/fpsyg.2021.734390. eCollection 2021.
4
5
Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial.同伴自我管理（PALS）：比较针对非裔美国狼疮女性疾病自我管理的同伴指导方法与社会支持对照：一项随机对照试验的研究方案。
Trials. 2019 Aug 23;20(1):529. doi: 10.1186/s13063-019-3580-4.
6
Evaluation of treatment adherence in patients with Behçet's disease: its relation to disease manifestations, patients' beliefs about medications, and quality of life.评价白塞病患者的治疗依从性：与疾病表现、患者对药物的信念和生活质量的关系。
Clin Rheumatol. 2019 Mar;38(3):761-768. doi: 10.1007/s10067-018-4344-3. Epub 2018 Oct 26.
7
Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.利用风湿病专科患者导航员了解并减少药物治疗依从性障碍：定性分析结果。
PLoS One. 2018 Jul 19;13(7):e0200886. doi: 10.1371/journal.pone.0200886. eCollection 2018.
8
Improving adherence to gout therapy: an expert review.提高痛风治疗的依从性：专家综述
Ther Clin Risk Manag. 2018 May 3;14:793-802. doi: 10.2147/TCRM.S162956. eCollection 2018.
9
Peer-to-Peer Mentoring for African American Women With Lupus: A Feasibility Pilot.非裔美国狼疮女性的朋辈指导：一项可行性试点研究。
Arthritis Care Res (Hoboken). 2018 Jun;70(6):908-917. doi: 10.1002/acr.23412. Epub 2018 Apr 18.
10
Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring.针对狼疮患者的有效自我管理干预措施：同伴指导的潜在影响。
Am J Med Sci. 2017 Jun;353(6):580-592. doi: 10.1016/j.amjms.2017.01.011. Epub 2017 Feb 3.
本文引用的文献
1
Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮患者对改善病情抗风湿药物的治疗依从性。
Int J Clin Rheumtol. 2010 Jun 1;5(3):313-326. doi: 10.2217/ijr.10.15.
2
3
Physician communication and patient adherence to treatment: a meta-analysis.医生沟通与患者治疗依从性：一项荟萃分析。
Med Care. 2009 Aug;47(8):826-34. doi: 10.1097/MLR.0b013e31819a5acc.
4
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.降尿酸药物治疗依从性不佳对血清尿酸及痛风相关医疗费用的影响：行政索赔分析
Curr Med Res Opin. 2009 Jul;25(7):1711-9. doi: 10.1185/03007990903017966.
5
Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs.类风湿关节炎患者皮下使用抗 TNF 治疗的依从性和费用变化趋势。
Curr Med Res Opin. 2009 Jun;25(6):1365-77. doi: 10.1185/03007990902896386.
6
Adherence to osteoporosis treatments: room for improvement.骨质疏松症治疗的依从性：仍有改善空间。
Curr Opin Rheumatol. 2009 Jul;21(4):356-62. doi: 10.1097/BOR.0b013e32832c6aa4.
7
Adherence with urate-lowering therapies for the treatment of gout.痛风治疗中尿酸降低疗法的依从性。
Arthritis Res Ther. 2009;11(2):R46. doi: 10.1186/ar2659. Epub 2009 Mar 27.
8
Comparison of methods to assess medication adherence and classify nonadherence.评估药物依从性及对不依从进行分类的方法比较。
Ann Pharmacother. 2009 Mar;43(3):413-22. doi: 10.1345/aph.1L496. Epub 2009 Mar 3.
9
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.提高药物依从性的预测：以双膦酸盐治疗骨质疏松症为例。
Med Care. 2009 Mar;47(3):334-41. doi: 10.1097/MLR.0b013e31818afa1c.
10
Depression, medication adherence, and service utilization in systemic lupus erythematosus.系统性红斑狼疮中的抑郁、药物依从性及服务利用情况
Arthritis Rheum. 2009 Feb 15;61(2):240-6. doi: 10.1002/art.24236.
Zotero 插件